These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 3665987
21. Cell proliferation and apoptosis during mammary carcinogenesis in pituitary isografted mice. Christov KT, Guzman RC, Swanson SM, Thordarson G, Talamantes F, Nandi S. Carcinogenesis; 1996 Aug; 17(8):1741-6. PubMed ID: 8761435 [Abstract] [Full Text] [Related]
22. Correlation of plasma prolactin and growth hormone with normal and preneoplastic mammary gland growth in virgin SHN mice. Nagasawa H, Nozaki D, Miura K, Niki K, Namiki H. Eur J Cancer Clin Oncol; 1985 Sep; 21(9):1109-11. PubMed ID: 4065183 [No Abstract] [Full Text] [Related]
30. Detection of inapparent nodule-transformed cells in the mammary gland tissues of virgin female BALB/cfC3H mice. DeOme KB, Miyamoto MJ, Osborn RC, Guzman RC, Lum K. Cancer Res; 1978 Jul; 38(7):2103-11. PubMed ID: 207423 [Abstract] [Full Text] [Related]
31. Inhibition by indomethacin of spontaneous mammary tumorigenesis in SHN mice. Nagasawa H, Naito T. Breast Cancer Res Treat; 1986 Jul; 8(3):249-55. PubMed ID: 3593988 [Abstract] [Full Text] [Related]
32. Relationship between mammary tumourigenesis and uterine adenomyosis in four strains of mice. Nagasawa H, Konishi R, Naito T, Ohmiya S, Mori T. In Vivo; 1987 Jul; 1(4):237-40. PubMed ID: 2979790 [Abstract] [Full Text] [Related]
33. Suppression of mammary hyperplastic nodule formation and pituitary prolactin secretion in mice induced by ergocornine or 2-bromo-a-ergocryptine. Yanai R, Nagasawa H. J Natl Cancer Inst; 1970 Dec; 45(6):1105-12. PubMed ID: 5530649 [No Abstract] [Full Text] [Related]
34. Development and characterization of mouse hyperplastic mammary outgrowth lines from BALB/cfC3H hyperplastic alveolar nodules. Ashley RL, Cardiff RD, Mitchell DJ, Faulkin LJ, Lund JK. Cancer Res; 1980 Nov; 40(11):4232-42. PubMed ID: 6258774 [Abstract] [Full Text] [Related]
35. Mammary tumorigenesis in chemical carcinogen-treated mice. VI. Tumor-producing capabilities of mammary dysplasias in BALB/cCrgl mice. Medina D. J Natl Cancer Inst; 1976 Nov; 57(5):1185-9. PubMed ID: 187796 [Abstract] [Full Text] [Related]
36. Differences in progression of BALB/cfRIII and BALB/cfC3H mammary hyperplastic alveolar nodules transplanted into the gland-free fat pads of BALB/c mice. Basolo F, Fontanini G, Squartini F. Cancer Res; 1988 Jun 01; 48(11):3197-202. PubMed ID: 2835155 [Abstract] [Full Text] [Related]
37. Hyperplastic alveolar nodules of the rat mammary gland: tumor-producing capability in vivo and in vitro. Sinha D, Dao TL. Cancer Lett; 1977 Jan 01; 2(3):153-60. PubMed ID: 402207 [Abstract] [Full Text] [Related]
38. Relationship between onset age of mammary tumour and reproduction in four strains of mice with different mammary tumour potentials. Nagasawa H, Ishii N. In Vivo; 1998 Jan 01; 12(3):345-9. PubMed ID: 9706482 [Abstract] [Full Text] [Related]